Activity in this selectionomers-266ca591
- Rounds participated in
- 2
- Confirmed lead rounds
- —
2 roles undisclosed- New companies
- 2
First participation on record · 0 follow-on- Funding in participating rounds
- $32.3M
2 disclosed · full round size, not this investor’s share
Rounds
2 in this selectionGenerareGenerates molecular data for drug development
Role not disclosedEGIDEDevelops electrically propelled interceptors and Mystique AI platform to counter low-cost drones
Role not disclosed